A plasma SNORD33 signature predicts platinum benefit in metastatic triple-negative breast cancer patients

Detalles Bibliográficos
Autores principales: Wang, Biyun, Zhao, Yannan, Li, Yi, Xu, Yingying, Chen, Yun, Jiang, Qiuyu, Yao, Dingjin, Zhang, Li, Hu, Xichun, Fu, Chaowei, Zhang, Si, Chen, She
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764855/
https://www.ncbi.nlm.nih.gov/pubmed/35042534
http://dx.doi.org/10.1186/s12943-022-01504-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764855/
https://www.ncbi.nlm.nih.gov/pubmed/35042534
http://dx.doi.org/10.1186/s12943-022-01504-0

Ejemplares similares